<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=129980757405201&amp;ev=PageView&amp;noscript=1">
AANP_Logo_Updated0418.png
iStock-539822068-2000x676.jpg

Choose Your Subscription Today!

Take Advantage of the special AANP-member rate that's right for you.

Stay Current on the Latest Developments in Drug Therapy and Medication Management

Let Prescriber's Letter help you find the practical advice you need to improve medication adherence, care quality, and reduce medication errors.  Prescriber's Letter recommendations are evidence-based, peer-reviewed, unbiased, and written in a concise and easy to digest format, so you can put timely information and resources into practice immediately. Prescriber's Letter advice is independent of drug company influence and accepts no advertising or outside funding.

Every month, you get access to 10+ recommendations on the latest, most relevant medication therapy topics for front-line prescribers and advance-practice clinicians.  With Prescriber's Letter, you can also access online resources that expand on new, monthly articles and guidance, such as:

  • Drug Comparison Charts
  • Patient Education Handouts (In English and Spanish)
  • FAQs
  • Clinical resource hubs on specific disease states
  • CE/CME credits for a variety of medication therapy topics, at no cost
  • Access to the live CE/CME Webinar series PL VOICES hosted by front-line clinicians, TRC editors and practice experts
  • On-demand access to all archived PL VOICES - Clinical Recommendations sessions, with CE/CME credit
  • Mobile access for answers anytime, anywhere, including our Apps for iPhone® and Android™ mobile devices

About Therapeutic Research Center

Therapeutic Research Center (TRC), home of Prescriber's Letter, is dedicated to providing care providers with the latest evidence-based, unbiased recommendations on new developments in drug therapy. In addition to our trusted web-based recommendations and printed letters, we also offer hundreds of CE courses, Live CE/CME webinars, and resource documents that expand on our recommendations.